AMPA receptor potentiators
The present invention relates to a compound of Formula (I) or a pharmaceutically acceptable salt thereof which is useful for the treatment of conditions associated with glutamate hypofunction, such as psychiatric and neurological disorders.
1. A compound of the formula:
or a pharmaceutically acceptable salt thereof.
2. A pharmaceutical formulation comprising a compound of the formula:
or a pharmaceutically acceptable salt thereof in combination with a pharmaceutically acceptable carrier, diluent or excipient.
3. The compound of claim 1 for use as a pharmaceutical.
4. A method of potentiating glutamate receptor function in a mammal comprising administering to a mammal in need of such treatment an effective amount of a compound of claim 1 .
5. A method of treating Parkinson's disease comprising administering to a mammal in need of such treatment an effective amount of a compound of claim 1 .
6. A method of treating depression comprising administering to a mammal in need of such treatment an effective amount of a compound of claim 1 .
7. A method of treating schizophrenia comprising administering to a mammal in need of such treatment an effective amount of a compound of claim 1 .